3.1600
+0.0300
+(0.96%)
At close: April 17 at 4:00:01 PM EDT
3.1100
-0.05
(-1.58%)
After hours: April 17 at 4:54:20 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-15,310
-15,310
77,919
-12,509
-53,525
Investing Cash Flow
-94,859
-94,859
-141,643
-7,339
65,906
Financing Cash Flow
114,015
114,015
33,645
1,110
612
End Cash Position
74,241
74,241
70,395
100,474
119,212
Capital Expenditure
-3,521
-3,521
-3,256
-2,491
-1,609
Issuance of Capital Stock
112,778
112,778
31,121
--
--
Free Cash Flow
-18,831
-18,831
74,663
-15,000
-55,134
12/31/2021 - 11/11/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RGNX REGENXBIO Inc.
5.94
-3.57%
WVE Wave Life Sciences Ltd.
5.92
+1.37%
IONS Ionis Pharmaceuticals, Inc.
28.40
+0.18%
SGMO Sangamo Therapeutics, Inc.
0.7056
+2.96%
CTMX CytomX Therapeutics, Inc.
0.6560
+4.18%
PTCT PTC Therapeutics, Inc.
47.39
+2.11%
BLUE bluebird bio, Inc.
4.1400
-0.24%
SAGE Sage Therapeutics, Inc.
7.43
+0.81%
ADVM Adverum Biotechnologies, Inc.
2.9300
-1.68%
QURE uniQure N.V.
13.00
+38.45%